GLP-1 medications like Wegovy and Mounjaro have changed the weight loss conversation. Millions of people are losing significant amounts of weight — and that's genuinely remarkable. But here's what the clinical data also shows: weight loss drugs reduce overall mass. They don't sculpt lines.
That chin pocket. The inner thigh gap that never appears no matter what the scale says. The stubborn flank roll. These areas don't respond to systemic weight loss — because fat distribution is genetic, and spot reduction through dieting or medication simply isn't possible.
💡 PLADEN's clinical finding: Over 60% of our international patients come to us after significant weight loss — precisely because they've lost the mass but haven't achieved the lines they wanted.
1. What Is a GLP-1 Drug — And What Can't It Do?
Wegovy (semaglutide) and Mounjaro (tirzepatide) are GLP-1 receptor agonists. They work by suppressing appetite and slowing gastric emptying, leading to reduced caloric intake and overall weight reduction.
What they cannot do:
- Target specific areas of fat accumulation
- Sculpt or define body contour
- Address loose skin or remaining localized deposits
- Change the ratio of fat between different body zones
2. How Fat Dissolving Injections Work
PLADEN's 3rd-generation fat dissolving formula works through a process called lipolysis — the targeted destruction of fat cell membranes in a specific, localized area.
The mechanism:
- Injection — The compound is administered directly into the subcutaneous fat layer of the target area
- Cell membrane disruption — The active ingredient breaks down fat cell walls
- Natural elimination — The body's lymphatic system clears the released fatty acids over 2–4 weeks
- Permanent reduction — Fat cells do not regenerate; the reduction is lasting
3. Side-by-Side: Wegovy vs. Fat Dissolving Injections
| Wegovy / GLP-1 | PLADEN Fat Dissolving | |
|---|---|---|
| Mechanism | Appetite suppression, systemic | Targeted lipolysis, local |
| Area control | ✗ No | ✓ Precise targeting |
| Downtime | Ongoing medication | Same-day return to daily life |
| Results | Weight reduction (whole body) | Line sculpting (specific zones) |
| Permanence | Reversed if medication stops | Fat cells permanently removed |
| Sessions | Ongoing weekly injection | 3–6 sessions, 2–4 weeks apart |
4. What PLADEN's Clinical Data Shows
Across over 60,000 patients treated since 2012, PLADEN's 3rd-generation protocol has demonstrated:
- 37% reduction in targeted fat cells per treatment area
- Average 2.9kg localized mass reduction
- 5.4cm reduction in thigh circumference (most common target area)
- 10-minute treatment time with no recovery period
📍 Who this is for: Patients who have already achieved their target weight (with or without medication) but still have specific areas of resistant fat that haven't responded to overall weight loss.
5. Frequently Asked Questions
Is fat dissolving painful?
Most patients rate discomfort at 2–3 out of 10. PLADEN applies topical numbing cream prior to treatment and uses ultra-fine needles. The procedure takes approximately 10 minutes.
How many sessions will I need?
The standard protocol is 3–6 sessions spaced 2–4 weeks apart. Most patients see visible change after session 2. The number of sessions depends on the target area, volume, and individual response.
Can I do fat dissolving while still on Wegovy?
Yes. The two treatments work through entirely different mechanisms and can be combined. Many PLADEN patients continue their GLP-1 medication while completing a sculpting protocol for specific areas.